Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

APP Accounts For 1% Of Premier Drug Spend: Response To Times Article

Executive Summary

American Pharmaceutical Partners accounts for 1% of drugs purchased by Premier, the company said

You may also be interested in...



GPO Self-Regulation Prescribed As Alternative To Congressional Action

GPO conflicts-of-interest will be one topic addressed by a group purchasing organization working group formed at the behest of Senate Judiciary/Antitrust Subcommittee Chairman Herbert Kohl (D-Wisc.)

GPO Self-Regulation Prescribed As Alternative To Congressional Action

GPO conflicts-of-interest will be one topic addressed by a group purchasing organization working group formed at the behest of Senate Judiciary/Antitrust Subcommittee Chairman Herbert Kohl (D-Wisc.)

GPO hearing details

Senate Judiciary/Antitrust Subcommittee is understood to be looking at April 30 as date for hearing on group purchasing organization practices. Witnesses are likely to include GPO executives (possibly Novation and Premier). General Accounting Office plans to submit preliminary findings from study of GPO practices. Primary focus of hearings is complaints by small medical device manufacturers about contracting practices, but investigations have spilled over to the pharmaceutical side (11"The Pink Sheet" April 1, p. 6)...

Related Content

UsernamePublicRestriction

Register

OM016808

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel